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Abstract: Recycled wastewater is widely used owing to the potential shortage of water resources 
for drinking purposes, recreational activities, and irrigation. However, gut microbiomes of both hu-
man beings and animals negatively affect this water quality. Wastewater contamination is continu-
ously monitored, using fecal contamination indicators or microbial source tracking approaches, to 
oppose arising enteric infections. Viral gastroenteritis is considered a principal manifestation of wa-
terborne pathogenic virome-mediated infections, which are mainly transmitted via the fecal-oral 
route. Furthermore, acquired enteric viromes are the common cause of infantile acute diarrhea. 
Moreover, public exposure to wastewater via wastewater discharge or treated wastewater reuse has 
led to a significant surge of public health concerns. In this review, we discussed the etiology of 
waterborne enteric viromes, notably gastrointestinal virus infections, and public exposure to mu-
nicipal wastewater. Conclusively, the early human virome is affected mainly by birth mode, dietary 
behavior, and maternal health, and could provide a signature of disease incidence, however, more 
virome diversification is acquired in adulthood. A multi-phase treatment approach offered an ef-
fective means for the elimination of wastewater reuse mediated public risks. The insights high-
lighted in this paper offer essential information for defining probable etiologies and assessing risks 
related to exposure to discharged or reused wastewater. 
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1. Introduction 
Virome diversity accounted for approximately 1031 members worldwide, including 
bacteriophages, as the major division according to a ten-fold diversity evaluation com-
pared to their bacterial hosts’ diversity [1]. Likewise, phage community dominates the 
early human enteric virome, along with the bacterial communities’ expansion acquired 
by maternal-mediated vertical transmission and after weaning [2,3]. On the other hand, 
enteric viruses in infants are minimally acquired from their mothers [4], however, the en-
teric viromes mostly persist after the first two years [2,5]. Several enteric viruses could 
transfer to infants, and even children, via maternal transmission, through direct exposure, 
or through the use of contaminated water, such as hepatitis E virus (HEV) and hepatitis 
A virus (HAV) causing gastroenteritis or, in severe cases, fulminant hepatitis [6–8]. 
However, adenovirus, rotavirus, norovirus, hepatitis A virus, and astrovirus repre-
sent the most commonly acquired enteric viruses and contribute to virome shaping in its 
early phases [6,9–12]. Moreover, these viruses are of high persistence in various water 
environments. For example, noroviruses can survive in ground water for 1266 days at 25 
°C with 1.76 log10 reduction [13]. However, adenoviruses can last for 36 and 132 days at 
20 °C and 4 °C, respectively, and are associated with a 1 log10 reduction [14]. Rotaviruses 
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can also persist in fresh water and drinking water for 10 [15] and 64 [16] days, respectively, 
at 20 °C with 2 log10 reduction. 
People are frequently exposed to wastewater via surface water usage, toilet flushing, 
recreation water, and wastewater—or greywater—dependent irrigation [17–21]. Most 
commonly occurring enteric viruses are self-limiting, whereas their infection risk is deter-
mined by the prevalence of infectious viral particles in the appropriate environmental 
condition, since some enteric viruses are significantly influenced by seasonal variation 
(e.g., rotavirus favoring late autumn and early winter [22]) or their prevalence in water 
environments that people are exposed to. For instance, the prevalence of HAV was found 
to be higher in raw water (16/27; 59%), than in treated water (5/26; 19%) [23]. 
Wastewater discharge to surface water resources imposes public health concerns and 
directly affects water resources, causing both enteric and non-enteric diseases, especially 
with the recent COVID-19 pandemic [24–26]. On the contrary, wastewater reuse was pro-
posed mainly because of the shortage of water supplies [27,28]. This demanded technical 
solutions for reuse of treated water for both non-potable uses, such as irrigation, with re-
ported limitations (e.g., alterations of soil physicochemical parameters, microbiota [29], 
soil fertility, and subsequent productivity [21] and soil pH [29]) to be considered and de 
facto wastewater reuse associated with raised concerns (e.g., increased drinking water 
risks in case of wastewater effluent in source water [30]). Integration of these technical 
solutions with a water safety plan (WSP) could offer organized management solutions for 
limitations and concerns. Thus, the current review highlighted the etiology of enteric vi-
romes in various water environments and the associated concerns related to public expo-
sure to municipal wastewater via wastewater discharge or treated water reuse. 
2. Enteric Virome in Infants 
The microbiome is established as early as the gestation period, and develops into a 
steady state as the individual reaches early adulthood [2,31–34]. Infant microbiomes were 
shown to be influenced by various factors involving birth mode, gestational age, antibiotic 
usage, geographical location, lifestyle, diet, and age [35–37]. For instance, a greater virome 
diversity was observed in spontaneous vaginal delivery (SVD) than in caesarean section 
(CS) [38]. Moreover, microbiome diversification during the early months after birth was 
found to be followed by a secondary expansive phase owing to diet alterations that occur 
after weaning [2,3,39]. Furthermore, microbiome composition of the infants’ gut is linked 
to that of the maternal gut [4,40,41]. However, it was demonstrated that vertical transmis-
sion of the virome was considerably lower than that of bacterial microbiome [4].  
Interestingly, antibiotic usage acts as a stressor, causing microbiome imbalances that 
are reported to cause sepsis in newborn infants by vertical transmission [42]. Antibiotic 
treatment reduces both the size and diversity of the bacterial community, initiates pro-
phage activation, and enriches phage-encoded antibiotic resistance genes that further in-
fluences the prokaryotic microbiome, which is associated with long-term implications 
[37,43–45]. Thus, such influences on the microbiome via these trans-domain interactions 
can be associated with probable metabolic deficiencies and inflammatory conditions [46–
49]. On the other hand, the infant virome is affected by dietary behavior and could serve 
as a signature of malnutrition. For instance, members of the Anelloviridae and Circoviri-
dae were found to discriminate between both healthy twin pairs and twin pairs develop-
ing malnutrition [50]. 
Although the microbiome is acquired during pregnancy or even at birth, the gut vi-
rome develops postnatally, since the meconium was found to lack any virus-like particles 
(VLPs) [51]. However, VLP numbers begin to surge to about 108 per g feces in the first 
birth week, along with the primary colonizers that arise from dietary and maternal 
sources in addition to the surrounding environment [52]. Consequently, the infantile vi-
rome expands and includes significant shifts in the phage community along with age be-
cause of the expansion and diversification of the bacterial communities [2]. Moreover, en-
teric virus communities in infants, accounting for 15%, are acquired from their mothers 
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[4]. The virome peak is reached at adulthood, displaying persistent viruses of about 80% 
that persist for >2.5 years [2,5]. Moreover, eukaryotic viruses, including adenovirus, her-
pes simplex virus, cytomegalovirus (CMV), human parvovirus B19, enterovirus, respira-
tory syncytial virus, and Epstein–Barr virus, were characterized from healthy mothers’ 
amniotic fluid, while neonates were healthy [53]. Furthermore, placental and vaginal 
transmission of viruses, comprising of HIV, influenza, hepatitis, CMV, rubella, and herpes 
zoster virus, were also detected, rendering extra evidence of maternal-mediated infantile 
virome modification [54]. This eukaryotic virome encompasses these conventional patho-
genic viruses and viruses of unidentified host interactions. Despite the presence of these 
classical pathogens, infected hosts can remain asymptomatic. 
On the other hand, waterborne enteric viruses, further, nourish the infantile virome 
either through maternal-based vertical transmission [55] or ingestion of contaminated wa-
ter or infant formula, as reported elsewhere [56]. For instance, acute maternal HAV infec-
tion could result in infant infection during the last trimester or the postpartum period [6]. 
Moreover, piped drinking water crossing sewage channels in India led to higher hepatitis 
E virus incidence in mothers, that was then vertically transmitted to fetuses [7]. Subse-
quently, two fetuses were aborted and four pre-matured babies were delivered [8]. There-
fore, an obvious relationship between the gastrointestinal virome in infants and water-
borne diseases or enteric viruses in wastewater is well-established and tightly linked to 
community behavior, life style, and infection risk via direct or indirect contact with con-
taminated water.  
3. Viral Etiology 
Viral gastroenteritis is mainly transmitted by the fecal-oral route. Currently, five 
common groups of viruses account for the most frequently occurring acute diarrheal cases 
worldwide: adenovirus, rotavirus, norovirus, hepatitis A virus, and astrovirus. 
3.1. Adenovirus 
Adenoviruses are members of the family Adenoviridae and the genus Mastadenovirus, 
comprising of more than 80 human serotypes [57]. Human adenoviruses are non-envel-
oped icosahedral particles with a double-stranded linear DNA genome of ~34–36 kb [58]. 
They are currently grouped into seven human adenovirus species (A-G), alongside novel 
adenovirus types that are continuously emerging [59,60]. Virus types were identified in 
cross-neutralization assays as serotypes up to type 51, however a genotype designation 
was used for the more recent types based upon phylogenetic analyses of genes encoding 
the major capsid proteins [61]. 
Adenovirus infections can lead to a wide spectrum of clinical symptoms. Gastroin-
testinal infections are commonly caused by subgroup A, D, and F, while subgroup B is the 
main cause of infections of the lungs and the urinary tract. Subgroups C and E are, how-
ever, mainly related to infections of respiratory tract. Amongst subgroup F, serotypes 40 
and 41, with serotype 31 of subgroup A, are mainly associated with gastroenteritis [62]. 
Adenovirus infections are mostly self-limiting, with the exception of immunocompro-
mised individuals. However, a strain of adenovirus 14 that emerged previously resulted 
in a fatal respiratory disease in healthy personnel [63]. 
Human adenoviruses (HAdV) are specific to humans even though adenoviruses in-
fect a range of animals. In domestic sewage, HAdV existed in notably high concentrations 
and their seasonal variability was insignificant [64–66]. As with most enteric viruses, ad-
enoviruses are more persistent in various water environments, including lakes, irrigation 
water, and treated sewage (Table 1), than the currently used fecal indicator bacteria 
[67,68]. For instance, adenovirus was detected in rivers (18–100%), recreational water (40–
93.1%), raw sewage water (0.4–100%), and treated effluents (25–100%, except for that re-
ported in earlier study conducted in Tunisia) as shown in Table 1. Moreover, adenovirus 
was of the highest concentrations, estimated at 9.8 × 108 GC/mL, in treated water influents 
and in treated effluents, at 4.9 × 108 GC/mL, in Italy. HAdV was of the highest frequency 
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(100%) in raw sewage water in all countries, except for the U.K. and Italy, wherein the 
encountered frequency was 90% and 96% in the same source, respectively. However, the 
highest HAdV concentration was obtained from lagoons and beaches in Brazil (109 GC/L). 
Furthermore, adenoviruses are highly resistant to UV light and this significant resistance 
might be due to the host cell-mediated DNA repair mechanism [69]. In addition, adeno-
viruses have another mechanism that ameliorates the DNA damage response, mediated 
by the E4 or F4 protein, which are involved in efficient adenovirus replication [70]. There-
fore, adenoviruses were proposed as a virological index for water quality control due to 
their potential environmental stability [71]. 
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a: mean adenovirus concentration, b: maximum adenovirus concentration, c: maximum detection 
limit (frequency), GC: genome copy. *: genome equivalent, **: treated water before chlorination, 
***: treated water after chlorination, ****: last storage reservoir before treatment of drinking water, 
(-): not defined. 
3.2. Rotavirus 
Rotavirus is a double stranded RNA virus composed of 11 segments of a genome size 
of ~18,550 bp [93]. These segments differ in size from 667 to 3302 nucleotides (Figure 1). 
Viral capsid proteins (VP1, VP2, VP3, VP4, VP6, and VP7) are encoded by segments 1, 2, 
3, 4, 6, and 9, respectively. The non-structural proteins (NSP1, NSP2, NSP3, NSP4, NSP5, 
and NSP6) are encoded by segments 5, 8, 7, 10, and 11, respectively. All segments have 
methylated cap structures at the 5′ end and a 3′UGACC consensus sequence instead of the 
poly-A tail [94,95]. 
 
Figure 1. Rotavirus genome structure. 
Rotaviruses are divided into seven serogroups (A-G) [96]. Rotavirus A is considered 
the principal cause of severe acute gastroenteritis throughout the world and predomi-
nantly results in severe acute diarrhea in children [97,98]. Moreover, the incidence of ro-
tavirus diarrhea in developing countries accounts for 0.07 to 0.8 episodes per child annu-
ally [99] or at least one diarrheal episode by five years of age [9]. Rotaviruses showed a 
high prevalence in different water sources (Table 2). This could be owing to its broad tol-
erance to a wide range of temperatures (−20 °C to 37 °C) and pH levels (3 to 11) without a 
significant infectivity loss [100–104]. However, rotavirus A prevalence is influenced by 
seasonal variations, favoring lower temperatures in temperate countries [22,105], unlike 
the endemic manner of rotavirus in tropical countries [106]. In terms of rotavirus fre-
quency, sewage influent of Brazil and, surprisingly, wastewater treatment plant (WWTP) 
effluents in China recorded the highest frequency, even higher than that reported in Chi-
nese raw water, indicating a deficiency in the WWTP performance or probable sampling 
cross-contamination, as shown in Table 2. Moreover, rotaviruses were detected in rivers 
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(18.75–83.33%), raw sewage water (21.2–100%), and treated effluents (5–100%). Further-
more, rotaviruses were detected at significantly high concentrations, up to 1.16 × 107 GC/L, 
in treated water influents and in treated effluents, at levels of 2.8 × 106 GC/L, in Brazil and 
the USA, respectively, as displayed in Table 2.  
The rotavirus outer capsid consists of two distinct neutralization antigens that are 
responsible for rotavirus attachment and entry, termed VP7 and VP4. They serve for virus 
classification, with each categorized into a G-genotype (16 genotype) and P-genotype (27 
genotype thus far) [98]. Despite the wide spectrum of rotavirus genotypes resulting from 
G/P combinations, epidemiological studies showed that the most prevalent genotypes are 
G1P(8), G3P(8), G4P(8), G9P(8), and G2P(4), which cause up to 90% of severe RVA infec-
tions worldwide [107,108]. Furthermore, there is no clear relationship between rotavirus 
genotypes and the severity of disease [109]. 
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a: in epidemic season, b: in non-epidemic season, c: mean detection frequency, d: mean rotavirus 
concentration, e: maximum detection frequency, f: maximum rotavirus concentrations, g: in up-
stream sites, h: in downstream sites. *: genome equivalent, GC: genome copy, (-): not defined. 
3.3. Norovirus 
Norovirus (NoV) is a member of the family Caliciviridae, with a polyadenylated, 
positive-sense, single-stranded RNA genome sized ~7.5 kb. The ≥ 40 genotypes are classi-
fied into seven genogroups (GI–GVII) [121,122]. NoV infection is considered the most 
prevalent non-bacterial mediated gastroenteritis, causing ~20% of entire gastroenteritis 
cases worldwide [123], particularly in five years old and younger children [124]. NoV 
causes ~685 million diarrheal episodes [125] and 200,000 deaths per year [126]. Norovirus 
infection symptoms occurs after an average incubation period of 24 to 48 h, typically in-
volving vomiting, nausea diarrhea, dehydration, fever, and abdominal cramps [127]. 
The NoV genome organization involves three or four open reading frames (ORFs). 
The first ORF (ORF1) encodes for six non-structural (NS) proteins, including NS1/2 (N-
Term), NS3 (NTPase), NS4 (3A-like), NS5 (VPg), NS6 (Protease), and NS7 (RNA-depend-
ent RNA polymerase; RdRp), which are responsible for viral replication. However, the 
other two ORFs (ORF2 and ORF3) encode two structural viral proteins (VP), comprising 
of VP1 (major) and VP2 (minor capsid protein), respectively (Figure 2) [128]. Norovirus 
typing was conventionally based upon sequence diversity within the capsid protein se-
quence. Noroviruses could be grouped into ten genogroups (GI-GX). Generally, 
genogroups vary by around 40–60% of their amino acid sequence: less sequence variance 
(20–40%) in the case of genotypes [129]. Moreover, genotypes can be sub-divided into var-
iants [130]. Currently, the RdRp-encoding region is used for dual genotyping of norovirus 
based on genotype and P type; GI.1[P1], for example [129]. 
 
Figure 2. Genome organization of norovirus. 
Humans can be infected by more than 30 genotypes of noroviruses. Furthermore, 
noroviruses show significant host specificity, which is at variance with evidence suggest-
ing inter-species transmission [131–133], in addition to the detection of viral RNA from 
human strains in different animals [133–137]. Initially, human strains of viral RNA dis-
played a potentially limited replication capacity in animals [138–140]. Moreover, GI and 
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GII viruses are mainly responsible for human infections [130], GIII viruses are associated 
with ovine and bovine species [141,142], GV viruses are specific for murine species (mice 
and rats) [143,144], and GIV, GVI, and GVII viruses are associated with various carnivo-
rous species, notably felines and canines [145–147]. Furthermore, GVIII and GIX, which 
are novel genogroups, were detected in humans, while GX was described in bats [129]. 
However, there are some exceptions to the species specificity of GII and GIV genogroups. 
For instance, GII.11, GII.18, and GII.19 were described in pigs [148], but not detected in 
humans, while GIV.1 and GIV.NA1 were associated with humans only, but not found in 
canines or felines [149]. 
Analyses of outbreaks identified GII noroviruses as the most frequently circulating 
strains causing gastrointestinal infections worldwide [150]. Over the past 20 years, GII.4 
became the predominant genotype, resulting in 70–80% of NoV outbreaks in various 
countries [151]. This genotype is potentially evolving, yielding new pandemic variants, 
including Grimsby 1995 (or US95_96), Farmington Hills 2002, Hunter 2004, Den Haag 
2006b, New Orleans 2009, and Sydney 2012 [152,153]. This strain diversity arises from 
both genome recombinations and mutational events, since significantly higher non-syn-
onymous changes were observed in comparison with other NoVs, supporting the anti-
genic drift proposal, although occurring at a higher rate [154,155]. 
Noroviruses are mainly transmitted via the fecal-oral route, through the ingestion of 
contaminated food or water, or by oral contact with a contaminated fomite existing in the 
surrounding environment [156]. Moreover, high rates of secondary infection arise via air-
borne transmission, although the fomite route is more dominant [157,158]. The biological 
characteristics of norovirus were extensively studied through human feeding study vol-
unteers [159–162]. Norovirus inocula as low as 10 viral particles were sufficient to initiate 
infection [161,163]. This potentially low count-mediated infection is regarded as highly 
critical when discussing norovirus survival. Strikingly, norovirus was depicted to be of 
stable infectivity under freezing and thawing conditions [164], although a more recent 
study showed altered stability upon exposure to three cycles of freezing and thawing 
[165]. Moreover, it shows a high capacity of survival in a wide spectrum of water bodies 
(Table 3), as well as thermal resistance, despite being exposure time-restricted to up to 21 
min decimal reduction time (time required at a given temperature to perform a log reduc-
tion) in the temperature range of 50–72 °C [166,167]. Furthermore, longer exposure time 
was detected at 50–60 °C, despite irreversible capsid disruption at >65 °C and loss of bind-
ing capacity at 72 °C [168]. This high survival capacity can be demonstrated in a norovirus 
outbreak that occurred in a long-term care facility in which fomite-mediated survival of 
norovirus resulted in a continuous infection for 14 days following the initial peak of illness 
[169]. Notably, noroviruses were detected in rivers (0–100%), recreational water (25–50%), 
raw sewage water (2.8–100%), and treated effluents (1.6–100%), as displayed in Table 3. 
Furthermore, noroviruses were detected at the highest concentrations, of 7.9 log10 GC/L, 
in combined wastewater in the USA (Table 3). 
Table 3. Norovirus occurrence in various water bodies. 
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a: mean norovirus concentration, b: maximum norovirus concentration, c: mean norovirus frequency, d: maximum no-
rovirus frequency. *: before mixing with wastewater, **: after mixing with wastewater, ‡: dominant genotype, †: genogroup 
I, ¥: genogroup II, ư: dead-end ultrafiltration (DEUF) samples, §: PCR-detectable units (PDU), ʘ: genome equivalent, GC: 
genome copy, (-): not defined. 
3.4. Hepatitis A Virus (HAV) 
The hepatitis A virus belongs to the family Picornaviridae, genus Hepatovirus, and 
is a non-enveloped positive-sense, single-stranded RNA virus of ~7.5 kb genome pack-
aged within a 27–32 nm icosahedral capsid [186]. The HAV genome is composed of a sin-
gle ORF, whose translation occurs by means of a cap-independent mechanism, making 
the use of the internal ribosome entry site (IRES) located upstream of the genome produc-
ing a polyprotein composed of ~2230 amino acids [187]. This polyprotein consists of three 
distinct domains (P1, P2, and P3), which are further processed into 10 mature proteins by 
the virus-encoded proteinase, 3Cpro [186,188]. P1 encodes the four major capsid proteins 
VP1-VP4. The nonstructural viral proteins are comprised of the polyprotein domains P2 
and P3, and also “processed” by 3Cpro [189]. HAV displays a high degree of conservation 
of the antigenic determinants—notably in amino acid sequences of viral capsids—now 
expanded to include the recently identified HAV-like viruses [190,191]. This could have 
resulted from negative selection pressures imposed upon any naturally-occurring mu-
tants, producing the observed consensus conservation [192]. Despite the high conserva-
tion of HAV, a degree of genomic sequence divergence exists defining the various HAV 
genotypes and the identity of sub-genogroups [192,193]. Consequently, HAV genotyping 
is dependent on different regions of its genome used to recognize HAV variants, including 
the VP1 entire region, notably the VP1 amino terminus, the 168 bp VP1–2A junction, the 
VP1–2B region, the VP3–2B region, the VP3 carboxy-terminus, and the 5′ untranslated re-
gion [194,195]. Based on VP1–2A junction region variability (of ~15%), seven genotypes of 
HAV were primarily defined. However, according to the 23.7% variation denoted by the 
entire VP1 sequence analyses, six HAV genotypes (I–VI) are currently defined, encom-
passing genotypes 1A, 1B, II, III, IV, V, and VI [196,197]. Genotypes I, II, and III infect 
humans and are divided into A and B subtypes, however genotypes IV to VI are called 
simian HAV (SHAV) since they infect non-human primates [196,198]. Amongst human 
HAV genotypes, subtype IA was found to be the most frequently circulating subtype 
worldwide [199]. Interestingly, individuals cannot be re-infected by HAV since the pres-
ence of a single HAV serotype results in the neutralization of IgG production against 
HAV, elicited upon vaccination or even natural infection [200]. 
On the other hand, HAV infections can range in associated severity from asympto-
matic to fulminant hepatitis-mediated deaths [201,202]. However, HAV commonly causes 
self-limiting infections that do not lead to chronic liver disease [200,203]. Moreover, clini-
cal manifestations can increase with age, manifested by jaundice, and unusually high se-
rum aminotransferase levels as the common symptoms, which are exhibited by over 70% 
of infected adult patients [201,204]. Furthermore, the incubation period of HAV lasts for 
~15–50 days, with an average of 28 days [205]. A wide range of symptoms occur upon 
HAV infection, including gastroenteritis, malaise, fever, nausea, anorexia, jaundice, dark 
urine (genitourinary symptom), and abdominal discomfort [206]. Fulminant hepatitis is 
considered as a rare complication associated with HAV infections that occurs in less than 
1% of infected patients, wherein the highest incidence rates occur in young children and 
the elderly with reported underlying liver illnesses [205,207]. Nucleotide substitutions at 
the 5′ UTR, P2, and P3 regions of the HAV genome were found to be associated with this 
fulminant disease [207,208]. 
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HAV is mainly transmitted via the fecal-oral route, as well as through personal con-
tact and exposure to contaminated water/food supplies, whereas transmission routes of 
the other typically hepatitis-causing viruses, in particular hepatitis B and C, involve con-
taminated blood or other body fluids via injection, intimate contact, or perinatal period 
vertical transmission [209]. Remarkably, waterborne HAV outbreaks are uncommon in 
developed countries owing to proper sanitation procedures, as well as water supply facil-
ities [210]. On the other hand, HAV was found to be of high stability and abundance in 
the surrounding water environments (Table 4) for long periods, whenever associated with 
organic matter [207,211]. For instance, HAV was detected to be infectious after more than 
one year of storage at 4 °C in bottled water, with <1 log reduction owing to concentrations 
of the added proteins [211,212]. Moreover, HAV shows significant resistance to surpris-
ingly low pH, since it was reported that infectivity remains after treatment at pH 1 for up 
to 5 h at room temperature, and for 1.5 h at 38 °C and a pH 3 for up to 21 days at 4 °C 
[213,214]. The environmental stability of HAV, displayed by its low pH as well as heat 
resistance (60 °C for 1 h), could be due to the inherent molecular stability of the HAV 
capsid, concurrent with its particular codon usage, along with the unique folding pattern 
of the VP2 protein [190,215,216]. Moreover, HAV was detected in rivers (1.19–76%), rec-
reational water (0–13.95%), raw sewage water (1.75–100%), and treated effluents (0–
64.7%), as shown in Table 2. In addition, HAV was detected at potentially high concentra-
tions, up to 6.0 × 106 GC/L, in treated effluents and, at 2.7 × 106 GC/L, in raw sewage water 
in Tunisia. 
Ingestion of HAV-contaminated food accounts for 2–7% of all HAV-mediated out-
breaks worldwide [217]. Epidemiological investigations provide a potential solution since 
they have succeeded previously in identifying the source of contamination. For example, 
a large and persistent food-borne mediated multi-state HAV outbreak occurred in Europe, 
from 2013 to 2014, which was determined to be due to the ingestion of HAV-contaminated 
frozen berries. This led to over 1589 cases and 2 deaths [218,219]. Moreover, bivalve mol-
luscan shellfish was reported to have significant HAV levels, showing various prevalence 
spatially and temporally [220–222]. For example, the prevalence of HAV severely declined 
over the years from 40% to <8%, according to the 20 year-systematic survey conducted on 
bivalve molluscan shellfish from three estuaries in Spain [220], accompanied by a reduc-
tion in HAV cases. However, the reduction in cases could be due to the increasing availa-
bility of the HA vaccine, alongside increased surveillance that can rapidly identify con-
taminated food [217,223]. 
Table 4. HAV abundance in water environments and prevalent genogroups. 
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a: mean HAV concentration, b: maximum HAV concentration. Υ: for surface water samples, ¥: for WWTP outflow water, ‡: 
dominant genotype, §: sewage polluted sea water, ◊: outbreaks data summary, GC: genome copy, (-): not defined. 
3.5. Astrovirus 
Human astroviruses (HAstV) are members of the family Astroviridae, genus Ma-
mastrovirus. They are non-enveloped icosahedral viruses, with a linear positive sense, 
single-stranded, RNA genome ranging from 6.4 -7.9 kb [238]. The genome consists of three 
ORFs, comprising of ORF1a, ORF1b, and ORF2, which are flanked by 5′ and 3′ UTRs (85 
and 83 nts, respectively) and a 3′ poly-A tail (Figure 3). ORF1a and ORF1b encode two 
functional polyproteins (nsp1a and nsp1ab), encompassing a serine protease and a RNA-
dependent RNA-polymerase (RdRp). ORF2 encodes the capsid proteins precursor, trans-
lated from a sub-genomic RNA (sgRNA), and comprises of two principal domains: the 
highly conserved amino (N)-terminus and the hypervariable carboxy (C)-terminus 
[239,240]. In addition, the viral genome encodes genomic linked protein (VPg) that plays 
a major role in viral infectivity (notably the TEEEY-like tract), the replication of the virus 
genome, and protein synthesis [241,242]. 




Figure 3. Genome structure of astrovirus. The hepanucleotide slippery sequence and the RNA hairpin structure acts as 
the frameshifting signal that produces ORF1b translation. ORF2 is a subset of sgRNA produced during virus replication. 
HAstV was commonly associated with the incidence of acute gastroenteritis in young 
children, immunocompromised individuals, and the elderly. HAstV is responsible for 
sporadic non-bacterial diarrheal cases, representing up to 20% and 0.5–15% of related out-
breaks [243–245]. HAstV is considered the second or third major cause of infantile gastro-
enteritis after rota- and calciviruses [246]. Nonetheless, regional studies demonstrate a 
significantly different relative prevalence of HAstV in water resources (Table 5) and clin-
ical settings. For instance, in particular developing countries, 30% of all diarrheal cases 
were due to HAstV infection [94,247]. Moreover, HAstV was detected in rivers (8.3–100%), 
seawater (4–11%), raw sewage water (40.2–100%), and treated effluents (0–84%), as dis-
played in Table 2. Moreover, HAstV was detected at the highest concentration estimated, 
4.3 × 107 GC/L, in raw sewage water in Uruguay in comparison to other countries. 
Gastroenteritis caused by HAstV is characterized by symptoms involving 2–3 day-
watery diarrhea, vomiting, abdominal pain, malaise, and headache [248]. The incubation 
period is somewhat longer than gastroenteritis caused by other types of virus at an aver-
age of 4.5 days [96,249]. HAstV encompasses eight genotypes, HAstV-1 to HAstV-8 [250], 
while HAstV-1 is the most common genotype identified in both wastewater and stools 
[251]. 
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a: maximum astrovirus concentration, b: maximum astrovirus detection frequency, c: mean astrovi-
rus concentration, d: mean astrovirus frequency, GC: genome copy. *: before mixing with 
wastewater **: after mixing with wastewater, §: genome equivalent, ‡: dominant genogroup/geno-
type, ∫: average quantification cycle (Cq), where low Cq values reflects high virus concentrations 
and vice versa, ‡: review study of epidemiological and microbiological characteristics of 89 water-
borne infectious intestinal outbreaks affecting England and Wales, (-): not defined. 
4. Public Exposure to Municipal Wastewater 
People are exposed to wastewater by various means (recreational activities, food pro-
duction, and agriculture). However, the infection risk due to waterborne enteric viruses 
is dependent on the infectious enteric viruses’ prevalence or their infectivity in various 
water environments that humans interact with (Table 6). For instance, infection risk due 
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to HAdV in drinking water accounted for 10−4/year for each person, which was quite sim-
ilar to astrovirus infection risk detected earlier in surface water in Mexico [87,263]. More-
over, HAdV and EV were found to be of the highest infectivity rate in secondary treated 
water and even in post-disinfection final effluent confirmed by cytopathic effect detection. 
However, a lower infectivity rate of HAdV and EV was detected in raw sewage (64%) and 
dam water (~65%), respectively (Table 6). Furthermore, infection risk was more reduced 
in surface water (10,000x/180 days and 10,000x/30 days) than in ground water (1000x/`213 
days and 10x/30 days) in the case of RV and AstV, respectively. The main exposure routes 
frequently include recreational activities and surface water drinking. Moreover, shellfish 
production is regarded as an indirect route of exposure, since molluscs are filter feeders 
and, consequently, contaminated water pathogens become concentrated and lead to con-
sumer infection [264,265]. Moreover, enteric viruses were detected using nested PCR for 
entero-, norwalk-like, and hepatitis A viruses and real-time PCR for adenovirus in 50% to 
60% of the total mussel samples (18) obtained from a bioremediation mussel farm [266]. 
Notably, non-enveloped viruses, such as noroviruses and the hepatitis A virus, can sur-
vive in the bivalves’ tissues and are highly resilient to degradation [267,268]. Moreover, 
virus particle size was found to determine whether the particle is degradation resistant or 
susceptible [265]. For example, <200 nm VLPs are typically of higher degradation re-
sistance when compared to bacteria [269]. Human infectious diseases owing to consump-
tion of contaminated filter-feeders and recreational activities in wastewater-polluted 
coastal waters account for USD 12 billion annually [270]. Moreover, wastewater-mediated 
irrigation, in particular sprinkler irrigation, generates aerosols that can cause infection 
upon direct exposure or ingestion of irrigated crops [271]. It is important to note that the 
RNA of the pandemic SARS-CoV-2 was detected in treated wastewater, representing a 
critical issue for usage in irrigation [272]. Therefore, SARS-CoV-2 RNA was investigated 
in various water resources for their incidence frequency (Figure 4) and prevalence using 
different genes (e.g., RdRP, S, N1, N2, N3, ORF1ab, and E) as genetic tracers [273–285]. 
However, the highest SARS-CoV-2 detection specificity was obtained when RdRP was 
applied in RT-qPCR and compared to other SARS-CoV-2 genes [286]. Furthermore, detec-
tion of SARS-CoV-2 RNA in treated wastewater is not usually associated with SARS-CoV-
2 infection risk, as reported in treated sewage of nine WWTPs in Germany [286]. This 
could be owing to the significantly higher persistence of SARS-CoV-2 RNA than infectious 
SARS-CoV-2 in water environments. Moreover, the persistence of infectious SARS-CoV-2 
in water environments is reliant on many factors, such as water source, temperature, and 
the initial virus titer. For instance, a T90 of infectious SARS-CoV-2 at room temperature 
was found 1.7 and 1.5 days in tap water and wastewater, respectively, that extended to 7 
days when a higher initial titer (105 TCID50/mL) was applied [26]. By comparison, the T90 
values declined in wastewater to a total of 15 min and 2 min at 50 and 70 °C, respectively 
[26]. Toilet flushing and groundwater production render other routes of direct exposure 
to wastewater [100,287]. 
Table 6. Infectivity of enteric viruses in different water resources. 
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HAdV: human adenovirus, RV: rotavirus, AstV: astrovirus, EV: enterovirus, ◊: infection risk (IR), including two parame-
ters: infection risk per person and infection risk reduction. Infection risk per person refers to the probability of infection 
occurrence for each person exposed to various water sources, whereas, infection risk reduction refers to the amount of risk 
reduction (RA) in case of water treatment (e.g., via disinfection or UV-treatment) or in case of being exposed for a period 
of time (represented in days) to different water environments. Ұ: Log10 reduction ¥: x fold reduction, a: average reduction, 
IVP: infectious virus particle, Pre-DIS: pre-disinfection (after secondary biological treatment), Post-DIS: post disinfection 
(final effluent), *: minimum infectivity rate (i.e., minimum number of infectious virus particles/site), **: % of samples that 
showed cytopathic effect (i.e., detection frequency of infectious virus particles), ***: average count of infectious virus par-
ticles out of total virus particles enumerated by qPCR and MPN PCR, §: in all four-treatment scenarios, ‡: residual infec-
tivity (x of the original virus titer), †: defined by cytopathic effect detection, (-): not defined. 




Figure 4. Frequency of SARS-CoV-2 RNA in various water environments [274,276–278,281–286,291]. SW: sewage water, 
TWW: Treated wastewater, RW: River water, SS: Wastewater sludge samples, Av.: Average frequency, for example, Av. 
SW: Average frequency of SARS-CoV-2 RNA in SW of countries that involved SW in their evaluation. 
5. Discharge of Wastewater 
Wastewater is commonly discharged into surface water resources. In addition to the 
public health concerns, fecal contamination of wastewater can negatively influence water 
environments essential for fishing, drinking water, and recreation. Enteric viruses are con-
sidered the main cause of waterborne illnesses associated with recreational water, includ-
ing pools, spas, rivers, etc., and can reach waters via the accidental release of feces or body 
fluids [292]. Moreover, a surge in non-enteric diseases was reported to arise from 
wastewater contaminated with significant viral contamination [24,25]. Wastewater treat-
ment (WWT) performance guidelines were established for reclamation and reuse (Table 
7). These guidelines are concerned with microorganism levels and the degree of treatment, 
whereas receiving waters risk management mainly depends on fecal indicator bacteria 
monitoring [293]. Unfortunately, these bacterial indicators cannot meet the full criteria of 
the ideal water quality indicators [294]. On the other hand, excreted enteric viruses can be 
detected in wastewater, but a wastewater treatment plant (WWTP) may not completely 
eliminate viruses in terms of their concentration and infectivity, thus demonstrating a con-
tinued water-related health risk [295]. Furthermore, enteric virus presence in water does 
not necessarily link to the bacterial indicators’ detection as Escherichia coli and coliforms 
[296]. Additionally, bacteriophage survival in water is more similar to human enteric vi-
ruses than the presently used bacterial indicators [293]. For instance, cross-assembly 
phage is currently implemented alongside pepper mild mottle virus (PMMoV) as the mi-
crobial source tracks markers simultaneously in this toolbox approach. This is owing to 
their inclusive distribution, associated with ever higher densities in sewage, than other 
detected viruses and the fact they follow a similar pattern to enteric viruses prevalence in 
different water bodies. Consequently, they are efficient as indicators of virus-mediated 
fecal pollution in lakes, rivers, and recreational waters [297–301]. Thus, traceability proce-
dures provide a mandate to determine fecal contamination sources so that the risk can be 
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Allowed Limit Average Limit Reference 
Irrigation 
(unrestricted) 






Total coliform <10 cfu/100mL - [303] 
Irrigation 
(unrestricted) 
Total coliform <10 cfu/100mL - [304] 
Gardens with 
access, ponds 
parks, crops and 
secondary 
contact recreation 
Total coliform <100 cfu/100ml - 
[305] 
Gardens and 













Food crops Total coliform <23 cfu/100mL 2.2 cfu/100mL 
[304] 




Total coliform <240 cfu/100mL 23 cfu/100mL 
Irrigation 
(unrestricted) 
Fecal coliform <1000 cfu/100mL - [305] 
Food crops Fecal coliform <400 cfu/100mL 200 cfu/100mL 
[304] 




Fecal coliform <23 cfu/100mL 2.2 cfu/100mL 
Irrigation 
(unrestricted) 
Fecal coliform <1 cfu/100mL - [302] 
Irrigation 
(unrestricted) 
Nematode egg <2 egg/L - [305] 
Irrigation 
(unrestricted) 
(Oo)cysts <1 cyst/50L - [302] 
(-): not applicable. 
6. Reuse of Treated Water 
The reusing of wastewater is determined by economic factors as it is often either used 
for the recirculation of organic matter, to act as natural fertilizers, or due to a shortage of 
water resources [27,28]. For instance, wastewater and greywater (households’ wastewater 
Water 2021, 13, 2794 26 of 40 
 
 
with no fecal contamination) were used for irrigation of agricultural products, as well as 
indoor activities involving toilet flushing and even for potable use [17–21]. However, in-
tensive treatment measures are required to meet the suggested wastewater reuse guide-
lines and, in particular, for greywater in which significant coliform loads may exist. How-
ever, the performance of treatment procedures relying on coliform elimination may be 
biased and exaggerated owing to the capability of these bacteria to multiply within the 
greywater system. 
Wastewater reuse is currently a frequent practice in many countries. For example, 
treated wastewater is utilized in agriculture and landscaping in many countries, including 
Egypt, Saudi Arabia, Italy, Cyprus, Malta, Spain, and the USA [306–310]. It is, for instance, 
used in Egypt for the irrigation of sandy soils to raise the organic matter content of soil 
and improve the capacity of cation exchange [311]. In Saudi Arabia in 2010, 25% of treated 
wastewater was used to irrigate landscapes in the public parks of a number of cities [312]. 
In the Netherlands, particularly in Amsterdam, wastewater is regarded as a rich resource 
of organic matter, including alginic acid, cellulose, bioplastic, biogas, and phosphorus ob-
tainment, that can be recovered and reused [313]. Moreover, wastewater reuse has con-
verted Singapore into a universal hydro-hub via the implementation of novel water tech-
nologies that allowed the nation to meet 30% of its water demands, a number that is set 
to increase to 55% by 2060 [314]. Wastewater reuse usually demands higher standards of 
treatment, since it may well contain higher pathogen content than greywater [315]. Grey-
water reuse is, therefore, much easier when separated from wastewater [316]. However, 
water contamination is possible in all pathways to an extent that necessitates adequate 
safety measures prior to the establishment of new systems. In this regard, Singapore has 
approved a potential multi-phase approach to water reuse, involving primary sedimenta-
tion, followed by activated sludge and microfiltration, and then ultrafiltration, reverse os-
mosis and, eventually, disinfection by ultraviolet radiation exposure [314]. This approach 
can also be highly beneficial to eliminate or significantly reduce public health risks asso-
ciated with the reuse of various wastewater streams. However, the targets should be well 
defined and technical solutions and proper assessment tools should be made available to 
ensure that it meets the recommended guidelines of safe water reuse. 
Technical solutions for reuse of treated water includes: (i) the employment of inno-
vative tools and technologies, such as the replacement of old equipment used for water 
treatment with new technologies, including membrane bioreactor (MBR)-based treatment 
[317,318], (ii) the establishment of an evaluation approach for determining water cost, that 
is energetic and equivalence-dependent, alongside treatment strategies [319], and (iii) 
solving the gap between water supply and water demand via desalination methodologies 
[320,321], control of runoff water [322], wastewater reuse [323], and cloud seeding [324]. 
However, the technical solution selection mandates the inclusion of a short costs analysis 
that depends on the nature of water reuse projects being chargeable or not [325]. For in-
stance, regenerated water use for industrial purposes or course irrigation in the private 
sector required investment costs that reached AUD >3/m3 in Australia [326] and up to EUR 
736/m3 produced/day in Spain, with an additional EUR 0.06/m3 to EUR 0.45/m3 for opera-
tional costs that varied according to the regenerated water uses and the required treatment 
[327]. On the contrary, regenerated water for water resources restoration and mainte-
nance, the recharging of aquifers, or reduction of treated effluent discharge into essential 
water bodies is not chargeable [325,328]. Technical solutions for water reuse should be 
assessed for, in particular, viral load reduction efficacy to avoid any associated health con-
cerns due to direct exposure. The MBR treatment process was found to be of higher effi-
ciency, in terms of both bacterial and virus removals, than the activated sludge process, 
which results in up to 2 log10 bacterial load reduction and lacks virus removal capability 
[329]. For example, adenoviruses and enteroviruses, and even infectious enteroviruses, 
were 3.7, 1.7, and 2log10 reduced, respectively, following MBR-based treatment in Saudi 
Arabia [318]. 
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Nevertheless, such efforts for the reuse of treated water, alongside the offered tech-
nical solutions, were opposed by serious limitations raised against irrigation using treated 
water. The alteration of the texture properties and physicochemical parameters of soil, 
due to agricultural reuse, led to changed microbiota and biomass [29]. Moreover, probable 
modifications of soil microbiota could influence soil fertility and subsequent productivity 
[21]. In addition, organic matter mineralization [330] and nutrients and metals availability 
[331,332] were affected by altered soil pH caused by irrigation with WWTP effluents. 
Therefore, reuse of insufficiently treated wastewater, or even raw water, could serve as 
alternative sources for irrigation, avoiding these risk factors [29]. However, other risk fac-
tors may emerge from the high burden of enteric pathogens. The norovirus disease bur-
den due to the consumption of lettuce irrigated with untreated greywater was assessed 
by QMRA model and revealed an annual disease burden fluctuation above the range of 2 
× 10−8 and 5 × 10−4 [333]. 
On the other hand, wastewater reuse is commonly practiced for potable purposes 
owing to the incidental presence of treated wastewater in a water supply source, termed 
de facto wastewater reuse. Upstream WWTP discharge was reported by the EPA as influ-
encing drinking water treatment plants (DWTPs), which included 2–16% of upstream 
wastewater discharges [334]. For instance, DWTPs, containing 50% upstream WWTP dis-
charges, were used to serve over 104 U.S. people, as reported in [335]. However, extensive 
risk assessment studies were concerned with the associated risks due to de facto reuse 
[30,336,337] and an annual risk of >1 infection/105 people was recorded [338]. Moreover, 
the median norovirus risk per year was the highest in the case of de facto reuse, when 
compared to other treatment scenarios, to such an extent that de facto reuse scenarios ex-
ceeded risk benchmarks (10−o). Alarmingly, 1% wastewater effluent was predicted to po-
tentially surge drinking water risks if contributed to the source water [30]. De facto reuse 
is still applicable globally and de facto reuse is expected to increase in the future due to 
an increased frequency of water supplies shortages and droughts [339]. 
The Water Safety Plan (WSP) is receiving increasing attention as a recommended risk 
management approach for water reuse. The establishment of the WSP approach organized 
drinking-water-related management practices and assured the applicability of these prac-
tices to drinking-water quality management. A WSP encompasses, at least, a system as-
sessment and effective operational monitoring and management to ensure drinking-water 
safety. Moreover, a WSP integrates various principles of other risk management ap-
proaches including, of a particular interest, the multiple-barrier approach and HACCP 
[340]. HACCP development presented an earlier framework for the improvement of 
drinking water treatment processes to minimize the probability of waterborne disease in-
cidence [341]. Moreover, repairing and maintaining the drinking water distribution net-
work was highlighted as a means of preventing drinking water contamination. In this 
regard, the necessity of HACCP implementation was reported in terms of avoiding mi-
crobial contamination incidence in drinking water treatment lines [342]. 
7. Conclusions 
The high persistence of enteric viruses in various water environments enabled their 
detection in almost all water sources with a significantly higher frequency. However, de-
tection frequency of enteric viruses could vary according to the virus type, geographical 
location, water source, and the assigned period for sampling, irrelevant to virus concen-
tration. Second, virus detection is not usually associated with virus infectivity, wherein 
the presence of infectious virus particles indicate infectivity and the resultant infection 
risk. Moreover, infection risk relies on detection specificity since the virus origin, whether 
of human origin or not, could determine the course of infection. For example, the RDRP 
gene of SARS-CoV-2 was found to be of higher specificity than other genes. On the other 
hand, exposure to wastewater discharge should be monitored and controlled for probable 
health issues. Consequently, a toolbox approach, implementing both pepper mild mottle 
virus and cross-assembly phage together, was highly encouraged for the traceability of 
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any possible fecal pollution. Moreover, MBR-based treatment for wastewater reuse was 
much more efficient in both bacterial and viral burden reduction than activated sludge, 
which cannot achieve virus removal. A WSP could likewise help in the quality manage-
ment of de facto wastewater reuse through the employment of HACCP throughout the 
wastewater treatment strategies. This review article provided the information necessary 
for decision making in terms of determining the most probable viral etiologies as well as 
evaluating the resultant risks associated with direct or indirect exposure to both dis-
charged or reused wastewater. 
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